KI-Beratung Beta

Produktbild: Adherence to Antipsychotics in Schizophrenia

Adherence to Antipsychotics in Schizophrenia

48,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

11.12.2013

Abbildungen

XII, 159 p. 10 illus., 1 illus. in color.

Verlag

Springer Italia

Seitenzahl

159

Maße (L/B/H)

24,1/16/1,6 cm

Gewicht

378 g

Auflage

Repr. 2012

Sprache

Englisch

ISBN

978-88--4702678-0

Beschreibung

Rezension

“Adherence
to Antipsychotics in Schizophrenia the issue of treatment adherence is
addressed from a series of viewpoints, with all of them converging in a valiant
attempt to provide a systematic overview of the aforementioned theme, and in
doing so becoming the central achievement and this book’s greatest value. … this
book to be a praiseworthy resource and of great help to all the professionals
in the field of mental health treating and caring for those suffering from
schizophrenia.” (Vjekoslav Peitl, Alcoholism and Psychiatry Research, Vol. 51 (2),
2015)

“This book reviews aspects influencing patients’ adherence to antipsychotic medications for the treatment of schizophrenia. … The audience includes individuals who are involved in the care of patients with schizophrenia, including psychiatrists. … anyone who cares for people suffering from schizophrenia could benefit from this book … . This book is very helpful, particularly on the nonpharmacological interventions that any providers can easily use to help their patients improve their adherence to antipsychotic medications and thus have better treatment outcomes.” (Aaron Plattner, Doody’s Book Reviews, May, 2014)



Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

11.12.2013

Abbildungen

XII, 159 p. 10 illus., 1 illus. in color.

Verlag

Springer Italia

Seitenzahl

159

Maße (L/B/H)

24,1/16/1,6 cm

Gewicht

378 g

Auflage

Repr. 2012

Sprache

Englisch

ISBN

978-88--4702678-0

Herstelleradresse

Springer-Verlag KG
Sachsenplatz 4-6
1201 Wien
AT

Email: ProductSafety@springernature.com

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Adherence to Antipsychotics in Schizophrenia
  • 1 Poor adherence to antipsychotic medication in people with schizophrenia: diffusion, consequences, and contributing factors.- Premise.- Role of antipsychotics in the treatment of schizophrenia.- Compliance versus adherence.- Assessment of medication adherence.- Frequency of poor adherence to antipsychotics.- Consequences of poor adherence to antipsychotics.- Determinants and moderators of adherence to antipsychotics.- Present and medium-term perspectives.- Closing Remarks.- 2 Pharmacological strategies to enhance adherence in schizophrenia.- Introduction.- Pharmacological factors contributing to non-adherence: efficacy, side effects, regimen, co-therapies.- First vs Second generation antipsychotics: efficacy, tolerability and the adherence issue.- Long-acting injectable antipsychotics.- Conclusion. 3 Non-pharmacological strategies to enhance adherence and continuity of care in schizophrenia.- Introduction.- Factors Influencing (non-)adherence in Schizophrenia.- Interventions to Enhance Adherence. Research and Clinical Evidence.- Comprehensive Review of Psychosocial and Programmatic Interventions to Enhance Adherence to Antipsychotic Medication in Schizophrenia.- Summary of Main Results and Evidences.- Conclusions and Future Directions.- 4 Psychological issues in improving adherence and alliance.- The patient-doctor relationship as a determinant of adherence to treatment.- Alliance and psychodynamic issues.- Towards the concept of concordance of the therapeutic project.